{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:29:54Z","timestamp":1785407394406,"version":"3.56.0"},"reference-count":32,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100022298","name":"Hualien Tzu Chi Hospital","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100022298","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005925","name":"Buddhist Tzu Chi Medical Foundation","doi-asserted-by":"crossref","award":["TCRD113-076"],"award-info":[{"award-number":["TCRD113-076"]}],"id":[{"id":"10.13039\/501100005925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005925","name":"Buddhist Tzu Chi Medical Foundation","doi-asserted-by":"crossref","award":["TCMF-CP 115-01"],"award-info":[{"award-number":["TCMF-CP 115-01"]}],"id":[{"id":"10.13039\/501100005925","id-type":"DOI","asserted-by":"crossref"}]},{"award":["TCRD113-076"],"award-info":[{"award-number":["TCRD113-076"]}],"id":[{"id":"https:\/\/ror.org\/04rbvc675","id-type":"ROR","asserted-by":"publisher"}]},{"award":["TCMF-CP 115-01"],"award-info":[{"award-number":["TCMF-CP 115-01"]}],"id":[{"id":"https:\/\/ror.org\/04rbvc675","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Background: Arterial stiffness is a major predictor of cardiovascular-related mortality in chronic kidney disease (CKD). While acrolein\u2014an endogenous reactive aldehyde that accumulates with declining renal function\u2014may be linked to vascular injury, its association with high peripheral arterial stiffness (HPAS) remains unclear. Methods: This cross-sectional study used the cardio-ankle vascular index (CAVI) to examine the association between serum acrolein levels and HPAS (CAVI \u2265 9.0) in 204 adults with non-dialysis CKD stages 3\u20135. Results: HPAS was identified in 90 patients (44.1%) and was associated with a higher prevalence of diabetes (p = 0.047), older age (p = 0.023), higher spot urine protein\u2013creatinine ratio (UPCR, p = 0.046), higher serum fasting glucose (p = 0.041), higher interleukin-6 (p = 0.025), and higher acrolein (p = 0.008). In multivariable logistic regression analysis, serum acrolein (odds ratio, 1.015; 95% confidence interval, 1.002\u20131.028; p = 0.025), age (p = 0.010), and UPCR (p = 0.046) remained independently associated with HPAS. Log-transformed acrolein was positively correlated with bilateral CAVI (all p &lt; 0.001) and log-transformed UPCR (p &lt; 0.001) but negatively correlated with the estimated glomerular filtration rate (p = 0.001). Conclusions: Elevated serum acrolein is independently associated with HPAS in non-dialysis CKD stages 3\u20135.<\/jats:p>","DOI":"10.3390\/toxins18060246","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T17:36:18Z","timestamp":1780076178000},"page":"246","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum Acrolein and Peripheral Arterial Stiffness in Non-Dialysis Chronic Kidney Disease: A Cross-Sectional Study"],"prefix":"10.3390","volume":"18","author":[{"given":"Ho-Hsiang","family":"Chang","sequence":"first","affiliation":[{"name":"Division of Nephrology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 97004, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9094-0589","authenticated-orcid":false,"given":"Yu-Li","family":"Lin","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 97004, Taiwan"},{"name":"School of Medicine, Tzu Chi University, Hualien 97004, Taiwan"},{"name":"Institute of Medical Sciences, Tzu Chi University, Hualien 97004, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5941-4414","authenticated-orcid":false,"given":"Chi-Chong","family":"Tang","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 97004, Taiwan"},{"name":"Institute of Medical Sciences, Tzu Chi University, Hualien 97004, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9239-6932","authenticated-orcid":false,"given":"Chiu-Huang","family":"Kuo","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 97004, Taiwan"},{"name":"School of Post-Baccalaureate Chinese Medicine, Tzu Chi University, Hualien 97004, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9549-9232","authenticated-orcid":false,"given":"Chih-Hsien","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 97004, Taiwan"},{"name":"School of Medicine, Tzu Chi University, Hualien 97004, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9364-4558","authenticated-orcid":false,"given":"Bang-Gee","family":"Hsu","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 97004, Taiwan"},{"name":"School of Medicine, Tzu Chi University, Hualien 97004, Taiwan"},{"name":"Institute of Medical Sciences, Tzu Chi University, Hualien 97004, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1093\/eurheartj\/ehaf167","article-title":"Cardiovascular disease in chronic kidney disease","volume":"46","author":"Cherney","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41581-022-00616-6","article-title":"Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease","volume":"8","author":"Matsushita","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ki.2012.131","article-title":"Arterial stiffness and pulse pressure in CKD and ESRD","volume":"82","author":"Briet","year":"2012","journal-title":"Kidney Int."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1681\/ASN.2019020117","article-title":"Arterial Stiffness in the heart disease of CKD","volume":"30","author":"Zanoli","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"101019","DOI":"10.1016\/j.jacadv.2024.101019","article-title":"Prognostic value of cardio-ankle vascular index for cardiovascular and kidney outcomes: Systematic review and meta-analysis","volume":"3","author":"Tavolinejad","year":"2024","journal-title":"JACC Adv."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1097\/HJH.0000000000000651","article-title":"Clinical assessment of arterial stiffness with cardio-ankle vascular index: Theory and applications","volume":"33","author":"Hayashi","year":"2015","journal-title":"J. Hypertens."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/ajh\/hpae022","article-title":"Cardio-ankle vascular index as a marker of left ventricular hypertrophy in treated hypertensives: Findings from the Pamela study","volume":"37","author":"Cuspidi","year":"2024","journal-title":"Am. J. Hypertens."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"629028","DOI":"10.1155\/2013\/629028","article-title":"Role of lipid peroxidation-derived \u03b1, \u03b2-unsaturated aldehydes in vascular dysfunction","volume":"2013","author":"Lee","year":"2013","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0006-291X(03)00716-2","article-title":"Increase in putrescine, amine oxidase, and acrolein in plasma of renal failure patients","volume":"305","author":"Sakata","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1196\/annals.1433.034","article-title":"Acrolein induces inflammatory response underlying endothelial dysfunction: A risk factor for atherosclerosis","volume":"1126","author":"Park","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/toxsci\/kfu233","article-title":"Molecular mechanisms of acrolein toxicity: Relevance to human disease","volume":"143","author":"Moghe","year":"2015","journal-title":"Toxicol. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"8682","DOI":"10.1038\/s41598-025-93698-8","article-title":"Acrolein exposure associated with kidney damage: A cross-sectional study","volume":"15","author":"Ma","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e000934","DOI":"10.1161\/JAHA.114.000934","article-title":"Acrolein exposure is associated with increased cardiovascular disease risk","volume":"3","author":"DeJarnett","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1042\/bst0310371","article-title":"Acrolein produced from polyamines as one of the uraemic toxins","volume":"31","author":"Sakata","year":"2003","journal-title":"Biochem. Soc. Trans."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1073\/pnas.95.9.4882","article-title":"Protein-bound acrolein: Potential markers for oxidative stress","volume":"95","author":"Uchida","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1002\/mnfr.201100182","article-title":"Protein modification by acrolein: Relevance to pathological conditions and inhibition by aldehyde sequestering agents","volume":"55","author":"Aldini","year":"2011","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1248\/bpb.b20-00522","article-title":"Cigarette smoke extract and its cytotoxic factor acrolein inhibit nitric oxide production in human vascular endothelial cells","volume":"43","author":"Horinouchi","year":"2020","journal-title":"Biol. Pharm. Bull."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Roumeliotis, S., Mallamaci, F., and Zoccali, C. (2020). Endothelial dysfunction in chronic kidney disease, from biology to clinical outcomes: A 2020 update. J. Clin. Med., 9.","DOI":"10.3390\/jcm9082359"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1681\/ASN.2014101047","article-title":"Uremic toxicity of advanced glycation end products in CKD","volume":"27","author":"Stinghen","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/ndt\/gfz012","article-title":"Receptor for advanced glycation end products: A key molecule in the genesis of chronic kidney disease vascular calcification and a potential modulator of sodium phosphate co-transporter PIT-1 expression","volume":"34","author":"Belmokhtar","year":"2019","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e146985","DOI":"10.1172\/JCI146985","article-title":"ALKBH1-demethylated DNA N6-methyladenine modification triggers vascular calcification via osteogenic reprogramming in chronic kidney disease","volume":"131","author":"Ouyang","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_22","first-page":"337","article-title":"Mechanism of acrolein-induced vascular toxicity","volume":"56","author":"Yousefipour","year":"2005","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/jnc.12336","article-title":"Acrolein stimulates the synthesis of IL-6 and C-reactive protein (CRP) in thrombosis model mice and cultured cells","volume":"127","author":"Saiki","year":"2013","journal-title":"J. Neurochem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ki.2011.341","article-title":"Antioxidant therapy in hemodialysis patients: A systematic review","volume":"81","author":"Coombes","year":"2012","journal-title":"Kidney Int."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/01.CIR.0000050628.11305.30","article-title":"The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: A randomized, controlled trial","volume":"107","author":"Tepel","year":"2003","journal-title":"Circulation"},{"key":"ref_26","first-page":"9604","article-title":"Acrolein: Formation, health hazards, and its control by dietary polyphenols","volume":"64","author":"Zhou","year":"2024","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_27","first-page":"CD006258","article-title":"Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease","volume":"2015","author":"Nistor","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1289\/ehp.1409251","article-title":"Acrolein exposure in U.S. tobacco smokers and non-tobacco users: NHANES 2005\u20132006","volume":"123","author":"Alwis","year":"2015","journal-title":"Environ. Health Perspect."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/mnfr.200700412","article-title":"Acrolein: Sources, metabolism, and biomolecular interactions relevant to human health and disease","volume":"52","author":"Stevens","year":"2008","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5551\/jat.32797","article-title":"The role of a novel arterial stiffness parameter, cardio-ankle vascular index (CAVI), as a surrogate marker for cardiovascular diseases","volume":"23","author":"Saiki","year":"2016","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Chern, Y.B., Wang, C.H., Liu, C.H., Liou, H.H., Tsai, J.P., and Hsu, B.G. (2025). Serum p-cresyl sulfate is associated with peripheral arterial stiffness in chronic hemodialysis patients. Diagnostics, 15.","DOI":"10.3390\/diagnostics15182353"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1161\/HYPERTENSIONAHA.118.11554","article-title":"Physiological diagnostic criteria for vascular failure","volume":"72","author":"Tanaka","year":"2018","journal-title":"Hypertension"}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/18\/6\/246\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T04:16:39Z","timestamp":1780200999000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/18\/6\/246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":32,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["toxins18060246"],"URL":"https:\/\/doi.org\/10.3390\/toxins18060246","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]}}}